MwanzoEVGN • NASDAQ
add
Evogene Ltd
$ 0.79
Baada ya Saa za Kazi:(2.72%)+0.021
$ 0.81
Imefungwa: 5 Mac, 18:00:01 GMT -5 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 0.84
Bei za siku
$ 0.73 - $ 0.84
Bei za mwaka
$ 0.73 - $ 2.42
Thamani ya kampuni katika soko
6.84M USD
Wastani wa hisa zilizouzwa
elfu 835.28
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 312.00 | -82.63% |
Matumizi ya uendeshaji wa biashara | 2.88M | -64.76% |
Mapato halisi | 3.87M | 150.77% |
Kiwango cha faida halisi | elfu 1.24 | 392.27% |
Mapato kwa kila hisa | -0.46 | 64.51% |
EBITDA | -2.44M | 64.22% |
Asilimia ya kodi ya mapato | -0.04% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 15.96M | -20.02% |
Jumla ya mali | 26.09M | -34.97% |
Jumla ya dhima | 8.83M | -68.31% |
Jumla ya hisa | 17.25M | — |
hisa zilizosalia | 8.72M | — |
Uwiano wa bei na thamani | 6.45 | — |
Faida inayotokana na mali | -22.70% | — |
Faida inayotokana mtaji | -39.13% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 3.87M | 150.77% |
Pesa kutokana na shughuli | -3.33M | 32.37% |
Pesa kutokana na uwekezaji | 10.91M | 441.12% |
Pesa kutokana na ufadhili | -10.34M | -318.34% |
Mabadiliko halisi ya pesa taslimu | -2.70M | -247.46% |
Mtiririko huru wa pesa | elfu -385.62 | -131.18% |
Kuhusu
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1999
Tovuti
Wafanyakazi
117
